Showing results (131-140 of 382) with videos related to
Sort By:
Pageof 39
BJU International|April 11, 2012
Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?Gina M Badalato, Josep M Gaya, Gregory Hruby, et al.The Canadian Journal of Urology|February 18, 2014
Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission databaseMichael A Gorin, Max Kates, Jeffrey K Mullins, et al.BJU International|April 19, 2017
Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims databaseMeera R Chappidi, Max Kates, Jeffrey J Tosoian, et al.Journal of the National Cancer Institute|April 5, 2017
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer TreatmentJames L Gulley, Ravi A Madan, Russell Pachynski, et al.Biotechniques|July 13, 2016
A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cellsJelani C Zarif, James R Hernandez, James E Verdone, et al.British Journal of Cancer|October 18, 2018
CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancerAkira Ooki, Christopher J VandenBussche, Max Kates, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector functionAmy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.The Prostate|August 12, 2009
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+Karen S Sfanos, Tullia C Bruno, Alan K Meeker, et al.The Journal of Pharmacology and Experimental Therapeutics|May 2, 2009
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationMoshe Yair Levy, Abhinav Sidana, Wasim H Chowdhury, et al.Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.Pageof 39